×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
NVAX – novavax, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
NVAX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/20
11:33 pm
nvax
Evaluating Novavax's Current Valuation After Steep Five Year Share Price Collapse [Yahoo! Finance]
Low
Report
Evaluating Novavax's Current Valuation After Steep Five Year Share Price Collapse [Yahoo! Finance]
12/16
01:37 pm
nvax
Pfizer leads COVID-19 vaccine peers lower after revamped guidance [Seeking Alpha]
Low
Report
Pfizer leads COVID-19 vaccine peers lower after revamped guidance [Seeking Alpha]
12/15
09:47 am
nvax
New Report Urges Action to Ensure Sustainable, Affordable Supply of Key Vaccine Adjuvants for Global Health Use [Yahoo! Finance]
Low
Report
New Report Urges Action to Ensure Sustainable, Affordable Supply of Key Vaccine Adjuvants for Global Health Use [Yahoo! Finance]
12/11
01:23 pm
nvax
Why I Wouldn't Touch Novavax With a 10-Foot Pole [Yahoo! Finance]
Low
Report
Why I Wouldn't Touch Novavax With a 10-Foot Pole [Yahoo! Finance]
12/10
04:10 am
nvax
Novavax (NASDAQ:NVAX) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Novavax (NASDAQ:NVAX) had its "sell (d)" rating reaffirmed by analysts at Weiss Ratings.
12/5
05:15 pm
nvax
Novavax, Inc. (NVAX): A Bull Case Theory [Yahoo! Finance]
Low
Report
Novavax, Inc. (NVAX): A Bull Case Theory [Yahoo! Finance]
12/1
03:01 pm
nvax
Pharma Stocks Fall After Leaked Memo Questions Vaccine Safety [Barron's]
Low
Report
Pharma Stocks Fall After Leaked Memo Questions Vaccine Safety [Barron's]
12/1
12:17 pm
nvax
Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino [Yahoo! Finance Canada]
Low
Report
Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino [Yahoo! Finance Canada]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/15
04:01 pm
nvax
Form 4 NOVAVAX INC For: Dec 11 Filed by: Casey Mark J
Low
Report
Form 4 NOVAVAX INC For: Dec 11 Filed by: Casey Mark J
11/12
04:18 pm
nvax
Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT
Low
Report
Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT
11/6
08:00 am
nvax
Form 8-K NOVAVAX INC For: Nov 06
Medium
Report
Form 8-K NOVAVAX INC For: Nov 06
11/6
07:48 am
nvax
Form 10-Q NOVAVAX INC For: Sep 30
Low
Report
Form 10-Q NOVAVAX INC For: Sep 30
11/4
06:09 am
nvax
Form 8-K NOVAVAX INC For: Nov 03
Medium
Report
Form 8-K NOVAVAX INC For: Nov 03
10/30
04:30 pm
nvax
Form 4 NOVAVAX INC For: Oct 29 Filed by: Rodgers Richard J
Low
Report
Form 4 NOVAVAX INC For: Oct 29 Filed by: Rodgers Richard J
10/22
07:01 am
nvax
Form 8-K NOVAVAX INC For: Oct 17
Low
Report
Form 8-K NOVAVAX INC For: Oct 17
10/14
07:45 am
nvax
Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT
Medium
Report
Form SCHEDULE 13D/A NOVAVAX INC Filed by: SHAH CAPITAL MANAGEMENT
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/14
Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at HC Wainwright from $10.00 to $17.00. They now have a "buy" rating on the stock.
40.5%
5/13 Form 4 NOVAVAX INC For: May 13 Filed by: Glenn Gregory M 30.6%
3/17 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00. 23.9%
11/27 Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at B. Riley. They set a "buy" rating and a $12.00 price target on the stock. 21.3%
1/21 Experimental-vaccine stocks jump amid spread of new virus in China [MarketWatch] 19.6%
3/24 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial 18.8%
4/8 Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May 15.3%
2/26 Novavax Advances Development of Novel COVID-19 Vaccine 14.5%
12/31 Form S-3 NOVAVAX INC 13.7%
6/27 Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities 12.6%
5/13 Form 4 NOVAVAX INC For: May 13 Filed by: Glenn Gregory M 30.6%
3/17 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating. They now have a $16.00 price target on the stock, up previously from $6.00. 23.9%
11/27 Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at B. Riley. They set a "buy" rating and a $12.00 price target on the stock. 21.3%
1/21 Experimental-vaccine stocks jump amid spread of new virus in China [MarketWatch] 19.6%
3/24 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial 18.8%
4/8 Novavax Identifies Coronavirus Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May 15.3%
2/26 Novavax Advances Development of Novel COVID-19 Vaccine 14.5%
12/31 Form S-3 NOVAVAX INC 13.7%
6/27 Novavax and Catalent Biologics Enter Strategic Partnership: Allowing Catalent Biologics to Expand Gene Therapy Footprint with Acquisition of Novavax’ Manufacturing Assets and Capabilities 12.6%
TOP News Decliners
3/2
Form 8-K NOVAVAX INC For: Mar 02
-28.2%
1/21 Form 424B5 NOVAVAX INC -22.9%
3/10 Epidemic response group ups coronavirus vaccine funding to $23.7 mln [Reuters] -20.5%
3/24 Novavax's stock rockets after late-stage trial for flu treatment achieves primary endpoints [MarketWatch] -18.5%
3/11 Form S-3ASR NOVAVAX INC -17.9%
3/14 Earnings Update: Novavax, Inc. Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance News] -16.3%
1/28 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -12.5%
3/25 Novavax, Inc. (NASDAQ: NVAX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -12.3%
5/8 Novavax Announces Reverse Stock Split of Common Stock -12.3%
4/21 Is This the Best Coronavirus Stock to Buy Now? [The Motley Fool] -11.2%
1/21 Form 424B5 NOVAVAX INC -22.9%
3/10 Epidemic response group ups coronavirus vaccine funding to $23.7 mln [Reuters] -20.5%
3/24 Novavax's stock rockets after late-stage trial for flu treatment achieves primary endpoints [MarketWatch] -18.5%
3/11 Form S-3ASR NOVAVAX INC -17.9%
3/14 Earnings Update: Novavax, Inc. Just Reported And Analysts Are Boosting Their Estimates [Yahoo! Finance News] -16.3%
1/28 Novavax, Inc. (NASDAQ: NVAX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. -12.5%
3/25 Novavax, Inc. (NASDAQ: NVAX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -12.3%
5/8 Novavax Announces Reverse Stock Split of Common Stock -12.3%
4/21 Is This the Best Coronavirus Stock to Buy Now? [The Motley Fool] -11.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: